Patent · US Active

Substituted 1,3,4-thiadiazoles as GLS1 inhibitors

US11230544B1 · kind B1 · utility

0Cited by

0References

21Claims

0Family size

Assignee

Medshine Discovery Inc. · CN

Inventors

Yonggang Liao · Shanghai, CN
Jun Lin · Taoyuan, TW
Chaonan Liu · Shanghai, CN
Changqing Wei · Shanghai, CN
Wenyuan Qian · Newbury Park, US
Chen ZHANG · Chengdu, CN
Zhen Gong · Shanghai, CN
Jian Li · Shanghai, CN
Shuhui CHEN · Shanghai, CN

Key dates

Filing date	Oct 15, 2019
Grant date	Jan 25, 2022
Priority date	—
Expiry date	Oct 15, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed is to a thiadiazole derivative and the uses thereof in preparing a drug for treating GLS1-associated diseases. Specifically disclosed is a derivative compound of formula (I), a tautomer thereof or a pharmaceutically acceptable composition thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.